Minapharm
-
Artes and Rhein Minapharm Continue Joint Product Development
Artes Biotechnology and Rhein Minapharm Biogenetics have jointly announced the production of a target of a therapeutic protein. The former applied its Hansenula technology platform and know-how to the generation of a therapeutic protein that was cho…
Minapharm | 01 January 2010
